Neurotech International (ASX:NTI)

Latest Article

Autism Trial Results a Major Boost for NTI’s Proprietary Tech & Children with Autism

Autism Trial Results a Major Boost for NTI’s Proprietary Tech & Children with Autism

Jul 10, 2018

Leading medical device company Neurotech International (ASX:NTI) this week reported highly promising results from US clinical trials of its Mente autism device.

READ ARTICLE

Related Neurotech International (ASX:NTI) articles

Revolutionary MedTech Device: a New Frontier in Autism Treatment

Revolutionary MedTech Device: a New Frontier in Autism Treatment

Jun 26, 2018

Today’s company has created the first and only regulated medical device for the management of autism in a home setting.

READ ARTICLE

Top Trending

ASX Junior’s Under-Drilled Cuban Oil Asset Puts it in Multi-Billion Barrel Company

ASX Junior’s Under-Drilled Cuban Oil Asset Puts it in Multi-Billion Barrel Company

Nov 15, 2018

READ ARTICLE

Zero Safety Issues for IMU’s Immunotherapy Cancer Treatment: Phase II Trial Imminent

Zero Safety Issues for IMU’s Immunotherapy Cancer Treatment: Phase II Trial Imminent

Nov 13, 2018

READ ARTICLE

ASX Ag-Tech Acquisition Provides Vantage Position in C$7.2B Canadian Weed Market

ASX Ag-Tech Acquisition Provides Vantage Position in C$7.2B Canadian Weed Market

Nov 9, 2018

READ ARTICLE

Neurotech International (ASX:NTI)
KEEP ME
INFORMED
SHARE
ASX Junior’s Under-Drilled Cuban Oil Asset Puts it in Multi-Billion Barrel Company